Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05523362 · ClinicalTrials.gov registry record · NA
Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes
A NA study, sponsored by Ian J. Neeland, MD.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT05523362 is a NA study that has completed, run by Ian J. Neeland, MD. The registered enrollment target is 56 participants.
The verdict
NCT05523362, a NA study, has completed, sponsored by Ian J. Neeland, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the feasibility and clinical utility of a continuous glucose monitoring device (CGM, Dexcom G6) for the care of patients with type 2 diabetes who are on non-insulin therapies.
Interventions
- DEVICE Dexcom continuous glucose monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2022-01-15 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05523362
The ClinicalTrials.gov registry entry for NCT05523362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ian J. Neeland, MD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom continuous glucose monitor is the first listed.
NCT05523362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05523362 about?
NCT05523362 is a clinical study titled "Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes". The objective of this study is to evaluate the feasibility and clinical utility of a continuous glucose monitoring device (CGM, Dexcom G6) for the care of patients with type 2 diabetes who are on non-insulin therapies.
What is the current status of trial NCT05523362?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2022-01-15. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT05523362?
The interventions under investigation include: Dexcom continuous glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT05523362?
This trial is sponsored by Ian J. Neeland, MD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.